Anadys Pharmaceuticals, Inc.

Icn Pharmaceuticals, Inc.

Other

Well Shield LLC

Ribapharm Inc.

Averett, Stewart Benson

Averett, Devron R.

Devron R Averett

Robert C Tam

Stewart Benson Averett

Kandasamy Ramasamy

Guangyi Wang

Stephen Evan Webber

Joseph R Lennox

Erik J Rueden

Alan X Xiang

David Louis Clark

Kanda S Ramasamy

Kanda Ramasamy

Rajanikanth Bandaru

Methods of reducing the incidence of healthcare-associated infections in various healthcare settings are provided. Methods for preventing or reducing the number of infections in a human or animal population are also provided. The methods as provided herein reduce the presence of various infectious agents that are commonly acquired or transmitted and are present on both animate and inanimate surfaces, including those infectious agents commonly found in healthcare settings. By reducing the presence of such infectious agents, the incidence of various types of infection or disease is thereby reduced.

Reduction of infections in healthcare settings using photocatalytic compositions

Provided is a photocatalytic composition comprising zinc (Zn) doped titanium dioxide (TiO) nanoparticles, wherein the ratio of titanium dioxide nanoparticles to zinc is from about 5 to about 150. The photocatalytic composition absorbs electromagnetic radiation in a wavelength range from about 200 nm to about 500 nm, and the absorbance of light of wavelengths longer than about 450 nm is less than 50% the absorbance of light of wavelengths shorter than about 350 nm.

Titanium dioxide photocatalytic compositions and uses thereof

Provided is a photocatalytic composition comprising zinc (Zn) doped titanium dioxide (TiO) nanoparticles, wherein the ratio of titanium dioxide nanoparticles to zinc is from about 5 to about 150. The photocatalytic composition absorbs electromagnetic radiation in a wavelength range from about 200 nm to about 500 nm, and the absorbance of light of wavelengths longer than about 450 nm is less than 50% the absorbance of light of wavelengths shorter than about 350 nm. Further provided is a method for treating or preventing microbial diseases and infestations in a plant and a method for increasing crop yield of a plant by applying the photocatalytic compositions taught herein to the surface of a plant. Also provided is a method for treating microbial diseases on a surface by applying the photocatalytic compositions taught herein to a surface illuminated by artificial light.

This invention relates to methods for treating or preventing hepatitis C virus infections in mammals using Toll-Like Receptor (TLR)7 ligands and prodrugs thereof. More particularly, this invention relates to methods of orally administering a therapeutically effective amount of one or more prodrugs of TLR7 ligands for the treatment or prevention of hepatitis C viral infection. Oral administration of these TLR7 immunomodulating ligands and prodrugs thereof to a mammal provides therapeutically effective amounts and reduced undesirable side effects.

Administration of TLR7 ligands and prodrugs thereof for treatment of infection by hepatitis C virus

The invention is directed to 3-&#x3b2;-D-ribofuranosylthiazolo[4,5-d]pyrimidine nucleosides and pharmaceutical compositions containing such compounds that have immunomodulatory activity. The invention is also directed to the therapeutic or prophylactic use of such compounds and compositions, and to methods of treating diseases and disorders described herein, by administering effective amounts of such compounds.

3-&#x3b2;-D-ribofuranosylthiazolo[4-5-d]pyrimidine nucleosides and uses thereof

[object Object]

The invention is directed to 3-&#x3b2;-D-ribofuranosylthiazolo[4,5-d]pyridimine nucleosides and pharmaceutical compositions containing such compounds that have immunomodulatory activity. The invention is also directed to the therapeutic or prophylactic use of such compounds and compositions, and to methods of treating diseases and disorders described herein, by administering effective amounts of such compounds.

3-&#x3b2;-D-ribofuranosylthiazolo[4-5-d]pyridimine nucleosides and uses thereof

Growing community of inventors

Cardiff by the Sea, CA, United States of America

Devron R Averett